NI201300063A - METHOD FOR THE TREATMENT OF AN INFECTION - Google Patents

METHOD FOR THE TREATMENT OF AN INFECTION

Info

Publication number
NI201300063A
NI201300063A NI201300063A NI201300063A NI201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A NI 201300063 A NI201300063 A NI 201300063A
Authority
NI
Nicaragua
Prior art keywords
compound
treatment
antibiotic
nsaid
infection
Prior art date
Application number
NI201300063A
Other languages
Spanish (es)
Inventor
Al Alawi Fadil
Frederick Leech Wayne
Nanjan Karthigeyan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46515931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201300063(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of NI201300063A publication Critical patent/NI201300063A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto inyectable cuando se utiliza para el tratamiento de una infección microbiana en una glándula mamaria de un animal, en el que el compuesto incluye a) un fármaco antiinflamatorio no esteroide (AINE); b) un antibiótico seleccionado del grupo de antibiótico betalactámico y un antibiótico macrólido; caracterizado porque el compuesto incluye un disolvente no acuoso, y el AINE y el antibiótico en el compuesto se disuelven en el disolvente no acuoso.An injectable compound when used for the treatment of a microbial infection in a mammary gland of an animal, wherein the compound includes a) a non-steroidal anti-inflammatory drug (NSAID); b) an antibiotic selected from the group of beta-lactam antibiotics and a macrolide antibiotic; characterized in that the compound includes a non-aqueous solvent, and the NSAID and the antibiotic in the compound are dissolved in the non-aqueous solvent.

NI201300063A 2011-01-20 2013-07-17 METHOD FOR THE TREATMENT OF AN INFECTION NI201300063A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ588686A NZ588686A (en) 2011-01-20 2011-01-20 Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland

Publications (1)

Publication Number Publication Date
NI201300063A true NI201300063A (en) 2014-05-23

Family

ID=46515931

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201300063A NI201300063A (en) 2011-01-20 2013-07-17 METHOD FOR THE TREATMENT OF AN INFECTION

Country Status (15)

Country Link
KR (1) KR101905173B1 (en)
CN (1) CN103327984B (en)
AU (1) AU2012207698A1 (en)
BR (1) BR112013018557B1 (en)
CL (1) CL2013002086A1 (en)
CO (1) CO6801732A2 (en)
CR (1) CR20130401A (en)
GT (1) GT201300182A (en)
IL (1) IL227540A (en)
MX (1) MX353876B (en)
NI (1) NI201300063A (en)
NZ (1) NZ588686A (en)
PE (1) PE20140035A1 (en)
WO (1) WO2012099479A1 (en)
ZA (1) ZA201305780B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995297A1 (en) * 2014-09-09 2016-03-16 Ceva Sante Animale Parenteral compositions and uses thereof
AR102172A1 (en) 2015-10-05 2017-02-08 Química Luar S R L A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION
CN105663037A (en) * 2016-01-27 2016-06-15 成都乾坤动物药业有限公司 Amoxicillin solution as well as preparation method and application thereof
CN112472667B (en) * 2019-08-23 2022-11-15 北京欧博方医药科技有限公司 Retxib long-acting injection and preparation method and application thereof
CN111035614B (en) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 High-content terramycin injection and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CN1297319C (en) * 2003-09-22 2007-01-31 王玉万 Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
EP1677781A4 (en) 2003-10-29 2008-11-19 Idexx Lab Inc Salts of pharmacologically active compounds
DE102004025324A1 (en) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation for veterinary medicine, process for their preparation and their use

Also Published As

Publication number Publication date
MX2013008407A (en) 2013-09-26
CN103327984B (en) 2016-08-17
AU2012207698A1 (en) 2013-04-18
ZA201305780B (en) 2014-04-30
CN103327984A (en) 2013-09-25
NZ588686A (en) 2013-07-26
GT201300182A (en) 2014-07-28
KR101905173B1 (en) 2018-11-28
BR112013018557A2 (en) 2016-11-22
IL227540A (en) 2017-12-31
CL2013002086A1 (en) 2014-07-25
IL227540A0 (en) 2013-09-30
CR20130401A (en) 2014-02-04
CO6801732A2 (en) 2013-11-29
KR20140012646A (en) 2014-02-03
WO2012099479A1 (en) 2012-07-26
MX353876B (en) 2018-02-01
PE20140035A1 (en) 2014-02-16
BR112013018557B1 (en) 2021-11-03

Similar Documents

Publication Publication Date Title
ECSP18005828A (en) METAL-BETA-LACTAMASE INHIBITORS
NI201300063A (en) METHOD FOR THE TREATMENT OF AN INFECTION
CL2016000698A1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors
CL2016002285A1 (en) Organic monobactam compounds for the treatment of bacterial infections
CY1118250T1 (en) CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE
CU24406B1 (en) 1 - {[(2S, 3S, 4S) -3-ETIL-4-FLUORO-5-OXOPIRROLIDIN-2-IL] METOXI} -7 -METOXIISOQUINOLIN-6-CARBOXAMIDA
CL2014003035A1 (en) Compounds derived from diazabicyclooctane, beta-lactamase inhibitors; pharmaceutical composition that includes them; process to prepare them; and method to treat a bacterial infection.
EA201000774A1 (en) BETA LACTAMASE INHIBITORS
BR112014000665A2 (en) compound, use thereof, pharmaceutical composition, antimicrobial agent, and method for preventing or treating a bacterial infection
CR11626A (en) BETA-LACTAMASA INHIBITORS
CL2008001631A1 (en) Compounds derived from substituted heterocycles, with the presence of a phenoxy group, reverse transcriptase inhibitors; pharmaceutical composition; and use in the treatment of HIV viral infections.
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
UY34342A (en) ? DERIVATIVES OF PIRROLOPIRIMIDINA AND PURINA ?.
CL2011001180A1 (en) Method and system for locating and tracking objects in the environment of a mine comprising defining areas, providing and operating radio systems to form a plurality of networks and visually presenting the relative positions of the various objects within the area of operations in a system of operations. screen.
BR112016013509A2 (en) “System for the administration of microbial inoculants and related materials and methods”.
CO2019002246A2 (en) Bicyclic Nitrogenous Heterocyclic Compound
AR105478A1 (en) FUNDABLE LIQUID AND SOLID DEGREES OF BURNS PROTECTED BY BURN
CL2019003051A1 (en) System to manage one or more photovoltaic devices. (divisional request 201800393)
CY1120016T1 (en) PHARMACEUTICAL FORMS OF ACP KASPOFUNGIN
EP3689333A4 (en) Two-drug type local injection solution for submucosal injection
WO2015024016A3 (en) 2-piperidinyl substituted n,3-dihydroxybutanamides
MX2020003665A (en) Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive.
CL2012003202A1 (en) Method for treating a recurrent gastrointestinal infection of clostridium difficile, which includes the administration of fidaxomycin and where the subject has undergone prior treatment to combat said infection.
EA201500941A1 (en) METHODS AND COMPOSITIONS FOR MODULATION OF THE GAMMA-GLUTAMIL CYCLE
CY1124227T1 (en) PASTE CONTAINING THE NON-STEROID ANTI-INFLAMMATORY DRUG MELOXICAM